Post-approval studies (Phase 4)Study completedNCT00311155
What this trial is testing
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 694
Showing 20 of 0 results